Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO 2020: Updates in renal cancer

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
5 Jun 2020

Highlights from ASCO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
5 Jun 2020

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway

Dr Neal Shore and Dr Elena Castro
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway ( Dr Neal Shore and Dr Elena Castro )
5 Jun 2020

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

Dr Brian Jonas - University of California Davis Comprehensive Cancer Center, Sacramento, USA
Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia ( Dr Brian Jonas - University of California Davis Comprehensive Cancer Center, Sacramento, USA )
3 Jun 2020

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Prof Benjamin Besse and Dr Alex Spira
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer ( Prof Benjamin Besse and Dr Alex Spira )
2 Jun 2020

Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
1 Jun 2020

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
1 Jun 2020

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
30 May 2020

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel

Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )
30 May 2020

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups

Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )
30 May 2020

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020